Clinical Trials Directory

Trials / Unknown

UnknownNCT02174367

An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasis

An Observational Cohort Study to Evaluate Factors Affecting Prevalence of Fatty Liver Disease and Fibrosis and Factors Affecting Response to Treatment in Patients With Psoriasis

Status
Unknown
Phase
Study type
Observational
Enrollment
400 (actual)
Sponsor
King's College London · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

• Main objectives and outcome measures. 1. Establish prevalence of and factors contributing to fatty liver disease and liver fibrosis in patients with psoriasis. Fatty liver disease diagnosed via ultrasound. Liver fibrosis diagnosed by liver biopsy or non-invasive tests of fibrosis including transient elastography, ultrasound, serum markers of fibrosis including procollagen-3-N-terminal peptide (P3NP). 2. Evaluate non-invasive markers of liver fibrosis in the psoriasis population. Namely transient elastography, standard liver function tests and P3NP. 3. Evaluate the impact of psoriasis disease severity and comorbidities including metabolic syndrome on response to treatment in patients with psoriasis. Data on co-morbid disease collected through questionnaires and review of medical records. Response to treatment assessed using psoriasis area and severity index (PASI) physician global assessment (PGA) and dermatology life quality index (DLQI). * Study population: 380 patients with moderate to severe psoriasis will be prospectively recruited to the study. * Chief investigator: Professor Jonathan Barker. Co-investigator: Professor Catherine Smith * Sponsor/funding organization: Pfizer and Biomedical Research Centre (BRC) at Guys and St Thomas Hospitals Trust

Conditions

Interventions

TypeNameDescription
DEVICETransient elastographya noninvasive tool for measuring liver stiffness as a predictor of liver fibrosis

Timeline

Start date
2012-11-01
Primary completion
2017-07-01
Completion
2021-07-01
First posted
2014-06-25
Last updated
2017-08-04

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02174367. Inclusion in this directory is not an endorsement.